Tumor microenvironment as a therapeutic target in cancer

2020/11/28 by Yi Xiao, Dihua Yu · 8 citations
Immunology and Microbiology · Medicine · #Cancer Cells and Metastasis #Cancer Immunotherapy and Biomarkers #Immune cells in cancer

paper · doi:10.1016/j.pharmthera.2020.107753

openalex publication_date 2020/11/28 · crossref created 2020/11/28 · crossref issued 2021/05/01 · crossref published 2021/05/01 · crossref published-print 2021/05/01 · openalex created_date 2025/10/10 · crossref deposited 2026/05/13 · openalex updated_date 2026/07/29 · crossref indexed 2026/07/30

Cited by

• Coptidis rhizoma and berberine as anti-cancer drugs: A 10-year updates and future perspectives
• GenAR: Next-Scale Autoregressive Generation for Spatial Gene Expression Prediction
• Role of tumor microenvironment composition and metabolism in lymphoid malignancies and therapeutic strategies
• Single‐Cell and Spatial Multiomics: Applications for Diseases
• Cutibacterium acnes –Derived Extracellular Vesicles Promote Epithelial Ovarian Cancer Progression by Activating the KEAP1 – NRF2 Antioxidant Pathway to Suppress Ferroptosis
• Targeting EZH2 in Cancer: From Molecular Mechanisms to Clinical Translation
• The role of tumor microenvironment and immune cell crosstalk in triple-negative breast cancer (TNBC): Emerging therapeutic opportunities
• Design and application of proton gradient-based pH-responsive nanomaterials in the tumor microenvironment